Current Value
$14.501 Year Return
Current Value
$14.501 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HY | 47.85% | $907.50M | -17.73% | 2.58% |
HASI | 46.95% | $3.26B | +12.48% | 5.81% |
CRCT | 44.14% | $1.23B | -0.70% | 3.39% |
ELAN | 41.01% | $5.78B | -22.67% | 0.00% |
GMRE | 38.75% | $522.40M | -25.24% | 10.40% |
GMED | 38.41% | $12.01B | +59.28% | 0.00% |
STWD | 38.26% | $6.40B | -7.28% | 9.87% |
AMRC | 37.91% | $1.26B | +0.89% | 0.00% |
CSTL | 37.40% | $713.07M | +31.44% | 0.00% |
VTOL | 37.22% | $1.02B | +38.46% | 0.00% |
FLGT | 36.37% | $523.95M | -35.26% | 0.00% |
LPX | 35.74% | $7.67B | +61.35% | 0.92% |
KD | 35.17% | $8.71B | +79.26% | 0.00% |
INGN | 34.91% | $252.95M | +96.67% | 0.00% |
SXI | 34.44% | $2.21B | +24.03% | 0.65% |
VRRM | 34.24% | $4.12B | +13.73% | 0.00% |
PAHC | 33.56% | $821.41M | +77.89% | 2.31% |
IQV | 33.44% | $35.93B | -6.93% | 0.00% |
BCO | 33.40% | $4.00B | +13.80% | 1.01% |
VCYT | 33.38% | $3.18B | +54.24% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RWAY | -0.01% | $420.00M | -11.71% | 14.19% |
RPD | 0.03% | $2.51B | -27.13% | 0.00% |
IMRN | 0.06% | $11.59M | +5.54% | 0.00% |
NXTC | 0.07% | $21.87M | -32.10% | 0.00% |
AVAL | -0.09% | $834.70M | -13.81% | 5.94% |
LUNR | 0.10% | $1.52B | +549.03% | 0.00% |
BACK | 0.13% | $2.44M | -46.22% | 0.00% |
UUU | 0.15% | $5.41M | +44.44% | 0.00% |
TTC | -0.18% | $8.32B | -8.64% | 1.75% |
LTRN | -0.18% | $37.64M | -10.74% | 0.00% |
XBIO | -0.19% | $6.57M | +16.39% | 0.00% |
TECX | 0.20% | $560.60M | +136.32% | 0.00% |
LMT | -0.22% | $114.83B | +5.81% | 2.62% |
NOC | 0.23% | $69.28B | -0.50% | 1.69% |
AOUT | -0.25% | $188.65M | +67.01% | 0.00% |
SMMT | -0.30% | $12.27B | +381.21% | 0.00% |
LPTH | 0.30% | $117.80M | +133.86% | 0.00% |
EWTX | 0.33% | $2.61B | +193.39% | 0.00% |
EQC | 0.35% | $184.61M | +29.06% | 0.00% |
KNSL | 0.35% | $10.01B | +10.65% | 0.13% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -20.79% | $75.37B | +21.54% | 0.45% |
CAH | -20.53% | $30.02B | +16.59% | 1.62% |
TRIP | -20.52% | $2.06B | -24.04% | 0.00% |
GO | -19.48% | $1.59B | -40.41% | 0.00% |
TMCI | -18.54% | $499.00M | -35.92% | 0.00% |
DV | -17.63% | $3.25B | -47.32% | 0.00% |
ZI | -12.52% | $3.35B | -36.27% | 0.00% |
BTCT | -12.36% | $20.96M | -19.65% | 0.00% |
DOCU | -12.12% | $18.20B | +43.80% | 0.00% |
CHD | -11.91% | $25.79B | +7.25% | 1.08% |
COR | -10.70% | $46.40B | +9.61% | 0.86% |
TEAM | -10.49% | $64.42B | +2.43% | 0.00% |
FLYW | -9.84% | $2.37B | -6.26% | 0.00% |
LZ | -9.77% | $1.37B | -25.14% | 0.00% |
MD | -9.23% | $1.17B | +43.19% | 0.00% |
TWLO | -8.85% | $16.67B | +50.94% | 0.00% |
MNOV | -8.77% | $93.68M | +25.66% | 0.00% |
TILE | -7.95% | $1.36B | +99.32% | 0.17% |
PRLB | -7.86% | $909.57M | +2.06% | 0.00% |
MANU | -7.81% | $2.73B | -23.87% | 0.00% |
Finnhub
Presenter SpeechCasey Woodring [Audio Gap] From the life science tools and diagnostics team here at JPM. I'm pleased to be joined today by the management team of Myriad Genetics. I'll turn it over
Finnhub
SALT LAKE CITY, Jan. 15, 2025 -- Myriad Genetics, Inc. , a leader in genetic testing and precision medicine, today announced select unaudited preliminary results for the fourth quarter and full...
Yahoo
Myriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador.
Yahoo
SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement with Hannah Storm, a nationally renowned sports broadcaster, who recently revealed her battle with breast cancer. Under the agreement, Storm will act as an ambassador for the Myriad Genetics Breast Cancer Risk Assessment Program featuring the MyRisk® with RiskScore® Hereditary Cancer Test, the first and industry-leading hereditary canc
Yahoo
News release updated to include the members of the management team speaking at the conference. SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CEO, and Sam Raha, COO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET). The presentation will be available through a live webcast in the
Yahoo
SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET). The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 44.15% | $68.90M | 0.5% |
PBE | 36.67% | $255.43M | 0.58% |
MORT | 36.55% | $281.17M | 0.43% |
IJS | 36.41% | $7.39B | 0.18% |
VIOV | 36.28% | $1.39B | 0.15% |
IWN | 36.16% | $11.95B | 0.24% |
SLYV | 36.06% | $3.88B | 0.15% |
CGW | 35.99% | $856.89M | 0.56% |
PRFZ | 35.96% | $2.51B | 0.39% |
XSHD | 35.90% | $62.67M | 0.3% |
SDIV | 35.85% | $747.64M | 0.58% |
NUSC | 35.68% | $1.21B | 0.31% |
VBR | 35.60% | $30.81B | 0.07% |
DFAT | 35.26% | $10.55B | 0.28% |
IJR | 35.25% | $86.08B | 0.06% |
PID | 35.21% | $809.17M | 0.53% |
SPSM | 35.01% | $12.16B | 0.03% |
DFSV | 35.00% | $4.09B | 0.31% |
IJJ | 34.99% | $8.33B | 0.18% |
IWM | 34.92% | $70.21B | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -22.38% | $195.31M | 0.85% |
USDU | -16.73% | $390.63M | 0.5% |
UUP | -14.00% | $640.67M | 0.77% |
WEAT | -13.33% | $121.69M | 0.28% |
CORN | -12.94% | $65.39M | 0.2% |
CTA | -12.22% | $536.34M | 0.76% |
TAIL | -11.91% | $65.48M | 0.59% |
AGZD | -7.78% | $142.77M | 0.23% |
EQLS | -7.60% | $8.93M | 1% |
DUSB | -5.05% | $928.78M | 0.15% |
SGOV | -4.02% | $31.15B | 0.09% |
JUCY | -3.35% | $298.75M | 0.6% |
MINT | -3.11% | $12.01B | 0.35% |
XBIL | -3.00% | $642.09M | 0.15% |
BILZ | -2.44% | $616.87M | 0.14% |
SOYB | -1.84% | $26.14M | 0.22% |
GBIL | -1.45% | $5.82B | 0.12% |
UNG | -1.36% | $820.81M | 1.06% |
FLOT | -1.30% | $7.88B | 0.15% |
KRBN | -0.34% | $200.77M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BUXX | 0.06% | $194.27M | 0.25% |
XHLF | -0.16% | $940.17M | 0.03% |
CCOR | 0.24% | $82.35M | 1.18% |
KRBN | -0.34% | $200.77M | 0.85% |
IBD | 0.49% | $332.90M | 0.44% |
MEAR | 0.49% | $774.87M | 0.25% |
PREF | 0.60% | $1.06B | 0.55% |
XONE | 1.15% | $541.55M | 0.03% |
FLOT | -1.30% | $7.88B | 0.15% |
SHV | 1.30% | $19.02B | 0.15% |
UNG | -1.36% | $820.81M | 1.06% |
VNLA | 1.38% | $2.32B | 0.23% |
TBLL | 1.40% | $2.00B | 0.08% |
GBIL | -1.45% | $5.82B | 0.12% |
SOYB | -1.84% | $26.14M | 0.22% |
HIGH | 2.41% | $279.53M | 0.52% |
BILZ | -2.44% | $616.87M | 0.14% |
TBIL | 2.48% | $4.81B | 0.15% |
YEAR | 2.80% | $1.19B | 0.25% |
ICLO | 2.87% | $287.48M | 0.2% |